# Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor

> **NCT05937815** · NA · UNKNOWN · sponsor: **University Hospital, Bordeaux** · enrollment: 253 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **PROCEDURE:** Sample collection

## Key facts

- **NCT ID:** NCT05937815
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09-13
- **Primary completion:** 2023-09-13
- **Final completion:** 2024-09-13
- **Target enrollment:** 253 (ESTIMATED)
- **Last updated:** 2023-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937815, "Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05937815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*